Update in the management of chronic lymphocytic leukemia, Journal of Hematology & Oncology, vol.2, issue.1, pp.29-36, 2009. ,
DOI : 10.1186/1756-8722-2-29
Chronic lymphocytic leukaemia, The Lancet, vol.371, issue.9617, pp.1017-1029, 2008. ,
DOI : 10.1016/S0140-6736(08)60456-0
URL : https://hal.archives-ouvertes.fr/pasteur-00838819
Molecular and cellular mechanisms of CLL: novel therapeutic approaches, Nature Reviews Clinical Oncology, vol.169, issue.7, pp.405-418, 2009. ,
DOI : 10.1038/nrclinonc.2009.72
Re-Establishment of a Normal Apoptotic Process as a Therapeutic Approach in B-CLL, Current Drug Target -Cardiovascular & Hematological Disorders, vol.3, issue.4, pp.261-286, 2003. ,
DOI : 10.2174/1568006033481384
Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression, Proceedings of the National Academy of Sciences, vol.99, issue.10, pp.6955-6960, 2002. ,
DOI : 10.1073/pnas.102181599
Apoptotic effects on B-cell chronic lymphocytic leukemia (B-CLL) cells of heterocyclic compounds isolated from Guttiferaes, Leukemia Research, vol.32, issue.12, pp.1914-1926, 2008. ,
DOI : 10.1016/j.leukres.2008.05.017
Establishment of a novel human B-CLL-like xenograft model in nude mouse, Leukemia Research, vol.29, issue.11, pp.1347-1352, 2005. ,
DOI : 10.1016/j.leukres.2005.04.017
A human B-cell CLL model established by transplantation of JOK-1 cells into SCID mice and an anti-leukemia efficacy of fludarabine phosphate., Oncology Reports, vol.7, pp.33-38, 2000. ,
DOI : 10.3892/or.7.1.33
Role of B-cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells, Leukemia, vol.19, issue.2, pp.223-229, 2005. ,
DOI : 10.1038/sj.leu.2403601
Therapeutic activity of two xanthones in a xenograft murine model of human chronic lymphocytic leukemia, Journal of Hematology & Oncology, vol.3, issue.1, p.49, 2010. ,
DOI : 10.1186/1756-8722-3-49
URL : https://hal.archives-ouvertes.fr/inserm-00668205